HealthDay News: Cancer
FDA Approves New Treatment for People With COPD
FRIDAY, Aug. 1, 2014 (HealthDay News) -- Patients with the
progressive, deadly respiratory ailment known as chronic
obstructive pulmonary disease (COPD) have a new weapon to battle
the disease, the U.S. Food and Drug Administration said
Some Birth Control Pills May Up Breast Cancer Risk
THURSDAY, July 31, 2014 (HealthDay News) -- Birth control pills
containing high doses of estrogen, along with some other
formulations, may increase the risk of breast cancer in women under
50, new preliminary research suggests.
Once-Daily Inhaler Approved for COPD
THURSDAY, July 31, 2014 (HealthDay News) -- Striverdi Respimat (olodaterol) inhalation spray has been approved by the U.S. Food and Drug Administration to treat chronic obstructive pulmonary disease (COPD), the agency said Thursday in a news release.
Annual COPD Costs To Hit $49 Billion by 2020: CDC
WEDNESDAY, July 30, 2014 (HealthDay News) -- Medical costs for
chronic obstructive pulmonary disease (COPD) in the United States
are more than $32 billion each year, according to new research from
the U.S. Centers for Disease Control and Prevention.
FDA Expands Use of Imbruvica for Form of Leukemia
MONDAY, July 28, 2014 (HealthDay News) -- Approved use for Imbruvica (ibrutinib) has been expanded to include people with chronic lymphocytic leukemia (CLL) who have a deletion in chromosome 17, the U.S. Food and Drug Administration said Monday in a news release.
Too Few Teens Receive HPV Shot, CDC Says
THURSDAY, July 24, 2014 (HealthDay News) -- An "unacceptably low" number of girls and boys are getting the human papillomavirus (HPV) vaccine, which protects against cervical, anal and other cancers, U.S. health officials said Thursday.